82 FR 10911 - National Institute on Drug Abuse; Notice of Closed Meetings
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 82, Issue 31 (February 16, 2017)
National Institutes of Health
Federal Register Volume 82, Issue 31 (February 16, 2017)
| Page Range | 10911-10912 | |
| FR Document | 2017-03081 |
[Federal Register Volume 82, Number 31 (Thursday, February 16, 2017)] [Notices] [Pages 10911-10912] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-03081] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; NIH Pathway to Independence Award (K99/R00). Date: February 27, 2017. Time: 12:30 p.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. [[Page 10912]] Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Susan O. McGuire, Ph.D., Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Blvd., Room 4245, Rockville, MD 20852, (301) 827-5817, mcguireso@mail.nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01; R34). Date: March 1, 2017. Time: 1:00 p.m. to 3:15 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Hiromi Ono, Ph.D., Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 4238, MSC 9550, Bethesda, MD 20892, (301) 827-5820, hiromi.ono@nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Mechanisms of Immune Activation and Inflammation: HIV Infection, ART, and Drugs of Abuse (R01). Date: March 16, 2017. Time: 9:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. Contact Person: Susan O. McGuire, Ph.D., Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Blvd., Room 4245, Rockville, MD 20852, (301) 827-5817, mcguireso@mail.nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; NIDA Core Center of Excellence Grant Program (P30). Date: March 22, 2017. Time: 9:00 a.m. to 11:30 a.m. Agenda: To review and evaluate grant applications. Place: Courtyard by Marriott, 5520 Wisconsin Avenue, Chevy Chase, MD 20815. Contact Person: Gerald L. McLaughlin, Ph.D., Scientific Review Officer, Office of Extramural Policy and Review, National Institute on Drug Abuse, NIH, DHHS, 6001 Executive Blvd., Room 4238, MSC 9550, Bethesda, MD 20892-9550, 301-827-5819, gm145a@nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; NIDA Research ``Center of Excellence'' Grant Program (P50). Date: March 22-23, 2017. Time: 11:30 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Courtyard by Marriott, 5520 Wisconsin Avenue, Chevy Chase, MD 20815. Contact Person: Gerald L. McLaughlin, Ph.D., Scientific Review Officer, Office of Extramural Policy and Review, National Institute on Drug Abuse, NIH, DHHS, 6001 Executive Blvd., Room 4238, MSC 9550, Bethesda, MD 20892-9550, 301-827-5819, gm145a@nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Multi-site Clinical Trials. Date: March 23, 2017. Time: 1:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Susan O. McGuire, Ph.D., Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive Blvd., Room 4245, Rockville, MD 20852, (301) 827-5817, mcguireso@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS) Dated: February 10, 2017. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017-03081 Filed 2-15-17; 8:45 am] BILLING CODE 4140-01-P
![Federal Register / Vol. 82, No. 31 / Thursday, February 16, 2017 / Notices 10911
opportunity for public comment on to address one or more of the following forward with our initiatives to ensure
proposed data collection projects, the points: (1) Whether the proposed success in accomplishing the NIH
Office of Extramural Research (OER), collection of information is necessary mission, input from partners and
the National Institutes of Health (NIH) for the proper performance of the customers is essential. Quality
will publish periodic summaries of function of the agency, including management principles have been
propose projects to be submitted to the whether the information will have integrated into OER’s culture and these
Office of Management and Budget practical utility; (2) The accuracy of the surveys will provide customer
(OMB) for review and approval. agency’s estimate of the burden of the satisfaction input on various elements of
DATES: Comments regarding this proposed collection of information, OER’s business processes. The
information collection are best assured including the validity of the approximately 14 (10 quantitative and 4
of having their full effect if received methodology and assumptions used; (3) qualitative) customer satisfaction
within 60 days of the date of this Ways to enhance the quality, utility, and surveys that will be conducted under
publication. clarity of the information to be this generic clearance will gather and
collected; and (4) Ways to minimize the measure customer and partner
FOR FURTHER INFORMATION CONTACT: To
burden of the collection of information satisfaction with OER processes and
obtain a copy of the data collection
on those who are to respond, including operations. The data collected from
plans and instruments, submit
the use of appropriate automated, these surveys will provide the feedback
comments in writing, or request more
electronic, mechanical, or other to track and gauge satisfaction with the
information on the proposed project,
technological collection techniques or NIH’s statutorily mandated operations
contact: Dr. Sherry Mills, Director,
other forms of information technology. and processes. OER/OD/NIH will
Office of Extramural Programs, OER, Proposed Collection Title: Generic
NIH, 6705 Rockledge Drive, Suite 350, present data and outcomes from these
Clearance for Surveys of Customers and
Bethesda, MD 20892, or call non-toll- surveys to inform the NIH staff, officers,
Partners of the Office of Extramural
free number (301) 435–2729, or Email leadership, advisory committees, and
Research of the National Institutes of
your request, including your address to: other decision-making bodies as
Health—Extension of 0925–0627—
OEPMailbox@mail.nih.gov. Formal appropriate. Based on feedback from
Office of the Director (OD), Office of
requests for additional plans and these stakeholders, OER/OD/NIH will
Extramural Research (OER), Office of
instruments must be requested in formulate improvement plans and take
Extramural Programs (OEP), National
writing. Institutes of Health (NIH). action when necessary.
SUPPLEMENTARY INFORMATION: Section Need and Use of Information OMB approval is requested for 3
3506(c)(2)(A) of the Paperwork Collection: OER develops, coordinates years. There are no costs to respondents
Reduction Act of 1995 requires: Written the implementation of, and evaluates other than their time. The total
comments and/or suggestions from the NIH-wide policies and procedures for estimated annualized burden hours are
public and affected agencies are invited the award of extramural funds. To move 1911.
ESTIMATED ANNUALIZED BURDEN HOURS
Average
Number of
Number of burden per Total annual
Type of respondent responses per
respondents response burden hour
respondent (in hours)
Quantitative Survey
Science professionals, applicants, reviewers, Institutional Officials ................ 1,500 1 20/60 500
Adult Science Trainees .................................................................................... 1,000 1 20/60 333
General Public ................................................................................................. 2,500 1 20/60 833
Qualitative Survey
Science professionals, applicants, reviewers, Institutional Officials ................ 200 1 1 200
Adult Science Trainees .................................................................................... 25 1 1 25
General Public ................................................................................................. 20 1 1 20
Dated: February 10, 2017. DEPARTMENT OF HEALTH AND as amended. The grant applications and
Lawrence A. Tabak, HUMAN SERVICES the discussions could disclose
Deputy Director, National Institutes of Health. confidential trade secrets or commercial
National Institutes of Health property such as patentable material,
[FR Doc. 2017–03137 Filed 2–15–17; 8:45 am]
and personal information concerning
BILLING CODE 4140–01–P National Institute on Drug Abuse; individuals associated with the grant
Notice of Closed Meetings applications, the disclosure of which
asabaliauskas on DSK3SPTVN1PROD with NOTICES
would constitute a clearly unwarranted
Pursuant to section 10(d) of the
invasion of personal privacy.
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is Name of Committee: National Institute on
hereby given of the following meetings. Drug Abuse Special Emphasis Panel; NIH
Pathway to Independence Award (K99/R00).
The meetings will be closed to the Date: February 27, 2017.
public in accordance with the Time: 12:30 p.m. to 3:30 p.m.
provisions set forth in sections Agenda: To review and evaluate grant
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., applications.
VerDate Sep<11>2014 19:05 Feb 15, 2017 Jkt 241001 PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 E:\FR\FM\16FEN1.SGM 16FEN1](https://thefederalregister.org/doc/82_FR_10942/page/1.svg)
![10912 Federal Register / Vol. 82, No. 31 / Thursday, February 16, 2017 / Notices
Place: National Institutes of Health, Place: Courtyard by Marriott, 5520 International Regulations for Preventing
Neuroscience Center, 6001 Executive Wisconsin Avenue, Chevy Chase, MD 20815. Collisions at Sea, 1972 (72 COLREGS),
Boulevard, Rockville, MD 20852 (Telephone Contact Person: Gerald L. McLaughlin, as amended. The special construction or
Conference Call). Ph.D., Scientific Review Officer, Office of
Contact Person: Susan O. McGuire, Ph.D., Extramural Policy and Review, National purpose of some vessels makes them
Scientific Review Officer, Office of Institute on Drug Abuse, NIH, DHHS, 6001 unable to comply with the light, shape,
Extramural Affairs, National Institute on Executive Blvd., Room 4238, MSC 9550, and sound signal provisions of the 72
Drug Abuse, National Institutes of Health, Bethesda, MD 20892–9550, 301–827–5819, COLREGS. Under statutory law 1 and
DHHS, 6001 Executive Blvd., Room 4245, gm145a@nih.gov. Coast Guard regulation,2 a vessel may
Rockville, MD 20852, (301) 827–5817, Name of Committee: National Institute on instead meet alternative requirements
mcguireso@mail.nih.gov. Drug Abuse Special Emphasis Panel; Multi- and the vessel’s owner, builder,
Name of Committee: National Institute on site Clinical Trials.
Drug Abuse Special Emphasis Panel; Multi- operator, or agent may apply for a
Date: March 23, 2017.
Site Studies for System-Level Time: 1:00 p.m. to 3:00 p.m. COAC. For vessels of special
Implementation of Substance Use Prevention Agenda: To review and evaluate grant construction, the cognizant Coast Guard
and Treatment Services (R01; R34). applications. District Office determines whether the
Date: March 1, 2017. Place: National Institutes of Health, vessel for which the COAC is sought
Time: 1:00 p.m. to 3:15 p.m. Neuroscience Center, 6001 Executive complies as closely as possible with the
Agenda: To review and evaluate grant Boulevard, Rockville, MD 20852 (Telephone 72 COLREGS, and decides whether to
applications. Conference Call).
Place: National Institutes of Health, Contact Person: Susan O. McGuire, Ph.D.,
issue the COAC. Once issued, a COAC
Neuroscience Center, 6001 Executive Scientific Review Officer, Office of remains valid until information
Boulevard, Rockville, MD 20852 (Telephone Extramural Affairs, National Institute on supplied in the COAC application or the
Conference Call). Drug Abuse, National Institutes of Health, COAC terms become inapplicable to the
Contact Person: Hiromi Ono, Ph.D., DHHS, 6001 Executive Blvd., Room 4245, vessel. Under the governing statute 3
Scientific Review Officer, Office of Rockville, MD 20852, (301) 827–5817, and regulation,4 the Coast Guard must
Extramural Affairs, National Institute on mcguireso@mail.nih.gov.
Drug Abuse, National Institutes of Health, publish notice of this action.
(Catalogue of Federal Domestic Assistance
DHHS, 6001 Executive Boulevard, Room Program Nos.: 93.279, Drug Abuse and The Commandant, U.S. Coast Guard,
4238, MSC 9550, Bethesda, MD 20892, (301) Addiction Research Programs, National certifies that the TUG CLAYTON W
827–5820, hiromi.ono@nih.gov. Institutes of Health, HHS) MORAN is a vessel of special
Name of Committee: National Institute on construction or purpose, and that, with
Drug Abuse Special Emphasis Panel; Dated: February 10, 2017.
Natasha M. Copeland, respect to the position of the navigation
Mechanisms of Immune Activation and
Inflammation: HIV Infection, ART, and Drugs Program Analyst, Office of Federal Advisory and towing lights, it is not possible to
of Abuse (R01). Committee Policy. comply fully with the requirements of
Date: March 16, 2017. [FR Doc. 2017–03081 Filed 2–15–17; 8:45 am] the provisions enumerated in the 72
Time: 9:00 a.m. to 5:00 p.m.
BILLING CODE 4140–01–P
COLREGS, without interfering with the
Agenda: To review and evaluate grant normal operation of the vessel. The
applications. Commandant further finds and certifies
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive DEPARTMENT OF HOMELAND that the sidelights (13′ 5.25″ from the
Boulevard, Rockville, MD 20852. SECURITY vessel’s side mounted on the pilot
Contact Person: Susan O. McGuire, Ph.D., house) and stern/towing lights (3′ 5.75″
Scientific Review Officer, Office of Coast Guard aft of frame 20 mounted on top of the
Extramural Affairs, National Institute on pilot house) are in the closet possible
Drug Abuse, National Institutes of Health, [Docket No. USCG–2017–0082]
compliance with the applicable
DHHS, 6001 Executive Blvd., Room 4245,
Certificate of Alternative Compliance provisions of the 72 COLREGS and that
Rockville, MD 20852, (301) 827–5817,
mcguireso@mail.nih.gov. for the TUG CLAYTON W MORAN full compliance with the 72 COLREGS
Name of Committee: National Institute on would not significantly enhance the
AGENCY: Coast Guard, DHS. safety of the vessel’s operation.
Drug Abuse Special Emphasis Panel; NIDA
Core Center of Excellence Grant Program ACTION: Notice.
This notice is issued under authority
(P30). of 33 U.S.C. 1605(c) and 33 CFR. 81.
Date: March 22, 2017. SUMMARY: The Coast Guard announces
Time: 9:00 a.m. to 11:30 a.m. that a Certificate of Alternative Dated: February 6, 2017.
Agenda: To review and evaluate grant Compliance (COAC) was issued for the Capt B.L. Black,
applications. TUG CLAYTON W MORAN. We are
Chief, Prevention Department, First District,
Place: Courtyard by Marriott, 5520 issuing this notice because its
U.S. Coast Guard.
Wisconsin Avenue, Chevy Chase, MD 20815. publication is required by statute.
Contact Person: Gerald L. McLaughlin, [FR Doc. 2017–03136 Filed 2–15–17; 8:45 am]
DATES: The Certificate of Alternative
Ph.D., Scientific Review Officer, Office of BILLING CODE 9110–04–P
Extramural Policy and Review, National Compliance was issued on January 30th,
Institute on Drug Abuse, NIH, DHHS, 6001 2017.
Executive Blvd., Room 4238, MSC 9550, FOR FURTHER INFORMATION CONTACT: For
Bethesda, MD 20892–9550, 301–827–5819, information or questions about this
asabaliauskas on DSK3SPTVN1PROD with NOTICES
gm145a@nih.gov. notice call or email Mr. Kevin Miller,
Name of Committee: National Institute on First District Towing Vessel/Barge
Drug Abuse Special Emphasis Panel; NIDA Safety Specialist, U.S. Coast Guard;
Research ‘‘Center of Excellence’’ Grant telephone (617) 223–8272, email
Program (P50).
Kevin.L.Miller2@uscg.mil. 1 33 U.S.C. 1605(c).
Date: March 22–23, 2017.
Time: 11:30 a.m. to 5:00 p.m. SUPPLEMENTARY INFORMATION: The 2 33 CFR 81.3.
Agenda: To review and evaluate grant United States is signatory to the 3 33 U.S.C. 1605(c).
applications. International Maritime Organization’s 4 33 CFR 81.18.
VerDate Sep<11>2014 19:05 Feb 15, 2017 Jkt 241001 PO 00000 Frm 00042 Fmt 4703 Sfmt 9990 E:\FR\FM\16FEN1.SGM 16FEN1](https://thefederalregister.org/doc/82_FR_10942/page/2.svg)
Document Created: 2018-02-01 15:02:23
Document Modified: 2018-02-01 15:02:23
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | February 27, 2017. | |
| FR Citation | 82 FR 10911 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR